Cancer Drug

DRL gets rights to commercialise proposed trastuzumab biosimilar in select LatAm, S-E Asia markets. Pharma major Dr. Reddy’s Laboratories has entered into a partnership with Prestige BioPharma under which it will get exclusive rights…

Nearly 100 per cent of patients who receive higher doses of cisplatin show some degree of permanent hearing loss. The ability to prevent this side-effect would dramatically improve the quality of life of childhood cancer survivors…